EE05197B1 - Linesoliid - kristallivorm II - Google Patents

Linesoliid - kristallivorm II

Info

Publication number
EE05197B1
EE05197B1 EEP200200420A EEP200200420A EE05197B1 EE 05197 B1 EE05197 B1 EE 05197B1 EE P200200420 A EEP200200420 A EE P200200420A EE P200200420 A EEP200200420 A EE P200200420A EE 05197 B1 EE05197 B1 EE 05197B1
Authority
EE
Estonia
Prior art keywords
linezolid
crystalline form
crystalline
Prior art date
Application number
EEP200200420A
Other languages
English (en)
Inventor
S. Bergren Michael
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22658183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05197(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of EE200200420A publication Critical patent/EE200200420A/et
Publication of EE05197B1 publication Critical patent/EE05197B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EEP200200420A 2000-02-02 2001-01-29 Linesoliid - kristallivorm II EE05197B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17983700P 2000-02-02 2000-02-02
PCT/US2001/000657 WO2001057035A1 (en) 2000-02-02 2001-01-29 Linezolid-crystal form ii

Publications (2)

Publication Number Publication Date
EE200200420A EE200200420A (et) 2003-12-15
EE05197B1 true EE05197B1 (et) 2009-08-17

Family

ID=22658183

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200420A EE05197B1 (et) 2000-02-02 2001-01-29 Linesoliid - kristallivorm II

Country Status (31)

Country Link
EP (1) EP1255754B1 (et)
JP (1) JP5235256B2 (et)
KR (3) KR100864745B1 (et)
CN (1) CN1221547C (et)
AR (1) AR027261A1 (et)
AT (1) ATE297920T1 (et)
AU (1) AU782138B2 (et)
BR (1) BR0107667A (et)
CA (1) CA2395603C (et)
CO (1) CO5261555A1 (et)
CZ (1) CZ302292B6 (et)
DE (1) DE60111497T2 (et)
DK (1) DK1255754T3 (et)
EA (1) EA004434B1 (et)
EE (1) EE05197B1 (et)
ES (1) ES2242728T3 (et)
HK (1) HK1051196A1 (et)
HU (1) HUP0301076A3 (et)
IL (1) IL151010A0 (et)
MX (1) MXPA02007471A (et)
MY (1) MY122829A (et)
NO (2) NO323459B1 (et)
NZ (1) NZ520541A (et)
PE (1) PE20011086A1 (et)
PL (1) PL356433A1 (et)
PT (1) PT1255754E (et)
SI (1) SI1255754T1 (et)
SK (1) SK287025B6 (et)
TW (1) TWI297687B (et)
WO (1) WO2001057035A1 (et)
ZA (1) ZA200205162B (et)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
ES2331454T1 (es) 2003-10-16 2010-01-05 Symed Labs Limited Forma cristalina de linezolid.
EP1737850B1 (en) 2004-04-19 2007-10-03 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
WO2006004922A1 (en) * 2004-06-29 2006-01-12 Teva Pharmaceutical Industries Ltd. Crystalline form iv of linezolid
WO2006110155A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof
CA2602073A1 (en) 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
KR20070062504A (ko) * 2005-06-22 2007-06-15 테바 파마슈티컬 인더스트리즈 리미티드 테가세로드 말레이트의 다형태
DE602006001699D1 (de) * 2005-07-20 2008-08-21 Teva Pharma Stabile pharmazeutische Zusammensetzung mit Linezolid Form IV
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
CA2703011A1 (en) * 2006-10-23 2008-10-23 Concert Pharmaceuticals Inc. Oxazolidinone derivatives and methods of use
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
EP2563781B1 (en) 2010-04-30 2016-10-26 Indiana University Research and Technology Corporation Processes for preparing linezolid
EP2603506A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
EP2603505A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
EP2593440A1 (en) * 2011-02-24 2013-05-22 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
WO2012119653A1 (en) 2011-03-09 2012-09-13 Synthon Bv Process for making crystalline form a of linezolid
CN102731341A (zh) * 2011-04-13 2012-10-17 上海医药工业研究院 用于制备利奈唑胺的中间体及其制备方法
CN102766106A (zh) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 利奈唑胺的新晶型及其制备方法
CN102399200B (zh) * 2011-12-14 2013-12-04 浙江新东港药业股份有限公司 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
EP2852580A1 (en) 2012-01-24 2015-04-01 Jubilant Life Sciences Ltd. Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) * 2012-04-10 2012-08-22 杭州华东医药集团生物工程研究所有限公司 一种利奈唑胺晶型及其制备方法
ES2603252T3 (es) 2012-11-09 2017-02-24 Synthon Bv Proceso para preparar linezolid
JP7251813B2 (ja) * 2017-11-16 2023-04-04 ペルシカ ファーマシューティカルズ リミテッド リネゾリド製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
CN1167701C (zh) * 1996-04-11 2004-09-22 法玛西雅厄普约翰美国公司 制备噁唑烷酮胺的方法
WO1999024393A1 (en) * 1997-11-07 1999-05-20 Pharmacia & Upjohn Company Process to produce oxazolidinones

Also Published As

Publication number Publication date
KR100864745B1 (ko) 2008-10-22
CZ20022635A3 (cs) 2002-10-16
CZ302292B6 (cs) 2011-02-09
ZA200205162B (en) 2003-09-29
DE60111497D1 (de) 2005-07-21
DK1255754T3 (da) 2005-08-22
SI1255754T1 (sl) 2005-12-31
DE60111497T2 (de) 2006-05-18
HK1051196A1 (en) 2003-07-25
MXPA02007471A (es) 2002-12-13
HUP0301076A3 (en) 2004-06-28
SK287025B6 (sk) 2009-10-07
PT1255754E (pt) 2005-11-30
EE200200420A (et) 2003-12-15
KR100781815B1 (ko) 2007-12-03
CO5261555A1 (es) 2003-03-31
AU782138B2 (en) 2005-07-07
JP5235256B2 (ja) 2013-07-10
CA2395603C (en) 2010-03-23
PE20011086A1 (es) 2001-10-04
IL151010A0 (en) 2003-02-12
NZ520541A (en) 2004-02-27
KR20070087178A (ko) 2007-08-27
NO323459B1 (no) 2007-05-14
EA200200819A1 (ru) 2003-02-27
ES2242728T3 (es) 2005-11-16
EA004434B1 (ru) 2004-04-29
KR20020072300A (ko) 2002-09-14
MY122829A (en) 2006-05-31
PL356433A1 (en) 2004-06-28
CN1221547C (zh) 2005-10-05
AU3275501A (en) 2001-08-14
SK9942002A3 (en) 2002-11-06
WO2001057035A1 (en) 2001-08-09
NO20023654D0 (no) 2002-08-01
ATE297920T1 (de) 2005-07-15
BR0107667A (pt) 2002-10-08
JP2003522175A (ja) 2003-07-22
KR20080044358A (ko) 2008-05-20
HUP0301076A2 (hu) 2003-08-28
AR027261A1 (es) 2003-03-19
EP1255754B1 (en) 2005-06-15
NO20065836L (no) 2002-08-01
NO20023654L (no) 2002-08-01
CA2395603A1 (en) 2001-08-09
CN1394207A (zh) 2003-01-29
EP1255754A1 (en) 2002-11-13
TWI297687B (en) 2008-06-11

Similar Documents

Publication Publication Date Title
DK1889838T3 (da) Thrombopoietin-mimetika
ATE290000T1 (de) Muscarinagonisten
ATE252099T1 (de) Biarylcarboxamide
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de) Thiazinoxazolidinon
DE50102988D1 (de) Bodenwischer
EE200200420A (et) Linesoliid - kristallivorm II
DE50100710D1 (de) Wischblatt
ATE298751T1 (de) 7-oxopyridoryrimidine
ATE262530T1 (de) Indolochinazolinone
DE10192638T1 (de) Bohrstangenladevorrichtung
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de) Sulfonylguanidine
DE10196064T1 (de) Halbleiterfotodektionsgerät
DE50100817D1 (de) Kugelgelenk
DE50011511D1 (de) Blowby-Heizung
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es) Antitranspirantes
ATE476423T1 (de) Benzoylpyridazine
DE10052925B4 (de) Schaukelbett
DE50007634D1 (de) Kardioplegieballonkatheter
DE10195909T1 (de) Viehfüttervorrichtung
NO20003491D0 (no) BagasjehÕndteringssystem
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
AR027982A1 (es) Aril- y heteroarilsulfonatos

Legal Events

Date Code Title Description
AA1Y Spc filed

Free format text: PRODUCT NAME: ZYVOX; REG NO/DATE: 00032/0259 05.01.2001

Spc suppl protection certif: C20100003

Filing date: 20100215

FC1Y Spc application refused

Free format text: PRODUCT NAME: ZYVOX; REG NO/DATE: 00032/0259 05.01.2001

Spc suppl protection certif: C20100003

Filing date: 20100215

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20120129